Pin‐I Hsu

822 total citations
16 papers, 603 citations indexed

About

Pin‐I Hsu is a scholar working on Surgery, Gastroenterology and Epidemiology. According to data from OpenAlex, Pin‐I Hsu has authored 16 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 8 papers in Gastroenterology and 6 papers in Epidemiology. Recurrent topics in Pin‐I Hsu's work include Helicobacter pylori-related gastroenterology studies (8 papers), Gastroesophageal reflux and treatments (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Pin‐I Hsu is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (8 papers), Gastroesophageal reflux and treatments (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Pin‐I Hsu collaborates with scholars based in Taiwan, China and United States. Pin‐I Hsu's co-authors include Gin‐Ho Lo, Huei‐Lung Liang, Deng‐Chyang Wu, Seng‐Kee Chuah, Wei‐Chen Tai, Chih‐Ming Liang, Shih‐Cheng Yang, Chien‐Ning Hsu, Jiunn‐Wei Wang and Tsung‐Hsing Hung and has published in prestigious journals such as PLoS ONE, International Journal of Environmental Research and Public Health and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Pin‐I Hsu

16 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pin‐I Hsu Taiwan 11 471 311 258 186 122 16 603
Stylianos Karatapanis Greece 15 311 0.7× 245 0.8× 261 1.0× 127 0.7× 125 1.0× 33 581
Ming‐Tsung Lin Taiwan 14 126 0.3× 298 1.0× 315 1.2× 60 0.3× 40 0.3× 34 483
Chiara Giordanino Italy 12 147 0.3× 250 0.8× 221 0.9× 37 0.2× 100 0.8× 21 401
J.M. Viver Spain 10 325 0.7× 181 0.6× 344 1.3× 278 1.5× 60 0.5× 15 514
Bùi Hữu Hoàng Vietnam 3 443 0.9× 49 0.2× 87 0.3× 209 1.1× 224 1.8× 3 510
Simone Diniz Carvalho Brazil 11 286 0.6× 92 0.3× 82 0.3× 78 0.4× 72 0.6× 22 342
Rocco Clemente Italy 10 503 1.1× 45 0.1× 87 0.3× 231 1.2× 244 2.0× 14 611
Loai Mansour Egypt 10 154 0.3× 237 0.8× 201 0.8× 75 0.4× 39 0.3× 22 379
Axel Hsu Hong Kong 8 163 0.3× 83 0.3× 108 0.4× 56 0.3× 134 1.1× 10 314
Yıldıran Songür Türkiye 9 139 0.3× 121 0.4× 129 0.5× 48 0.3× 110 0.9× 25 327

Countries citing papers authored by Pin‐I Hsu

Since Specialization
Citations

This map shows the geographic impact of Pin‐I Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pin‐I Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pin‐I Hsu more than expected).

Fields of papers citing papers by Pin‐I Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pin‐I Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pin‐I Hsu. The network helps show where Pin‐I Hsu may publish in the future.

Co-authorship network of co-authors of Pin‐I Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Pin‐I Hsu. A scholar is included among the top collaborators of Pin‐I Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pin‐I Hsu. Pin‐I Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Liang, Chih‐Ming, Wei‐Chen Tai, Pin‐I Hsu, et al.. (2020). Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan. Therapeutic Advances in Gastroenterology. 13. 30 indexed citations
2.
3.
Wu, Deng‐Chyang, Pin‐I Hsu, Chao‐Hung Kuo, et al.. (2019). <p>Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial</p>. Drug Design Development and Therapy. Volume 13. 1347–1356. 5 indexed citations
4.
Wu, Cheng‐Kun, Chih‐Ming Liang, Wei‐Chen Tai, et al.. (2018). Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan. International Journal of Environmental Research and Public Health. 15(12). 2655–2655. 13 indexed citations
5.
Chuah, Seng‐Kee, Shih‐Cheng Yang, Chih‐Ming Liang, et al.. (2018). Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis. PLoS ONE. 13(5). e0197127–e0197127. 15 indexed citations
6.
Wang, Jiunn‐Wei, Chien‐Ning Hsu, Chih‐Ming Liang, et al.. (2018). Association between Helicobacter pylori eradication and the risk of coronary heart diseases. PLoS ONE. 13(1). e0190219–e0190219. 29 indexed citations
7.
Hung, Tsung‐Hsing, Chih‐Ming Liang, Chien‐Ning Hsu, et al.. (2017). Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan. PLoS ONE. 12(7). e0181858–e0181858. 29 indexed citations
8.
Wu, Cheng‐Kun, Chih‐Ming Liang, Chien‐Ning Hsu, et al.. (2017). The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation. PLoS ONE. 12(1). e0169884–e0169884. 6 indexed citations
9.
Yang, Shih‐Cheng, Chien‐Ning Hsu, Chih‐Ming Liang, et al.. (2017). Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study. PLoS ONE. 12(1). e0168918–e0168918. 10 indexed citations
10.
Liang, Chih‐Ming, Pin‐I Hsu, Chao‐Hung Kuo, et al.. (2017). First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease. World Journal of Gastroenterology. 23(47). 8395–8404. 7 indexed citations
11.
Wang, Jiunn‐Wei, Chien‐Ning Hsu, Wei‐Chen Tai, et al.. (2016). The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases. PLoS ONE. 11(10). e0164824–e0164824. 12 indexed citations
12.
Liang, Chih‐Ming, Chien‐Ning Hsu, Wei‐Chen Tai, et al.. (2016). Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis. Medicine. 95(36). e4795–e4795. 14 indexed citations
13.
Chuah, Seng‐Kee, Wei‐Chen Tai, Pin‐I Hsu, et al.. (2012). The Efficacy of Second‐Line Anti‐Helicobacter pylori Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot Study. Helicobacter. 17(5). 374–381. 58 indexed citations
14.
Hu, Hong‐Ming, Fu‐Chen Kuo, Pin‐I Hsu, et al.. (2009). Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. Journal of Antimicrobial Chemotherapy. 63(5). 1017–1024. 79 indexed citations
16.
Cheng, Jin‐Shiung, Kwok‐Hung Lai, Gin‐Ho Lo, et al.. (2000). Gastrointestinal metastasis in hepatocellular carcinoma: Radiological and endoscopic studies of 11 cases. Journal of Gastroenterology and Hepatology. 15(5). 536–541. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026